Your session is about to expire
← Back to Search
standard care for Cachexia (MENAC Trial)
Phase 3
Waitlist Available
Research Sponsored by Norwegian University of Science and Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
MENAC Trial Summary
This trial will test whether an early, multi-component intervention can prevent cancer cachexia in patients with solid tumours starting chemotherapy.
Eligible Conditions
- Cachexia
- Tumors
MENAC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
change in body weight
Secondary outcome measures
change in muscle mass
change in physical activity
MENAC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: multimodal interventionExperimental Treatment4 Interventions
standard care plus multimodal intervention consisting of nutritional supplements and advice, home-based self-assisted exercise program, and anti-inflammatory medication (ibuprofen)
Group II: standard careActive Control1 Intervention
standard palliative care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ibuprofen
2013
Completed Phase 4
~5800
Find a Location
Who is running the clinical trial?
St. Olavs HospitalOTHER
522 Previous Clinical Trials
286,207 Total Patients Enrolled
1 Trials studying Cachexia
150 Patients Enrolled for Cachexia
Chelsea and Westminster NHS Foundation TrustOTHER
75 Previous Clinical Trials
59,367 Total Patients Enrolled
Oslo University HospitalOTHER
1,069 Previous Clinical Trials
1,294,067 Total Patients Enrolled
2 Trials studying Cachexia
63 Patients Enrolled for Cachexia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger